Rigorous test-negative design study with large real-world population (73,160 cases) over 15 years demonstrating vaccine effectiveness against the target pathogen with precise confidence intervals; not practice-changing because vaccination policy was already implemented.
A modelling study using machine learning to project future disease burden; lacks direct clinical outcomes, relies on historical registry data and predictive algorithms rather than intervention trials, and acknowledges critical data limitations that prevent causal inference on vaccine effects.
A modeled cost-effectiveness analysis from a single healthcare system showing the intervention meets the threshold, but dependent on assumptions about treatment duration and subsequent costs that proved sensitive in scenario testing.
This is a comprehensive narrative review synthesizing evidence on immunotherapy's current role in nasopharyngeal carcinoma management, drawing on completed and ongoing clinical trials to inform clinical practice and research priorities.
Cross-sectional survey of awareness and intention in a single university cohort with low actual vaccination rates; descriptive and exploratory rather than comparative, and provides no interventional evidence.
A single-centre cross-sectional survey with self-reported vaccination status and no clinical outcomes; findings describe a gap but cannot establish causation or guide clinical practice changes.
Modelling study based on a single trial's survival data, assessing cost-effectiveness in a specific healthcare system; does not itself evaluate clinical outcomes and depends on external trial evidence and assumptions.
This is a comprehensive review article synthesizing mechanistic knowledge of innate immune responses across major RNA and DNA viruses, intended to inform therapeutic strategy development rather than report new empirical findings.